Showing results (851-860 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|May 21, 2026
Assessing the impact of pharmacist-led interventions on glucagon-like peptide 1 receptor agonist access and treatment outcomesHaley Huddleston, Jodi Martinez, Jerilyn Cook, et al.Journal of Managed Care & Specialty Pharmacy|May 21, 2026
Prevalence, adherence, and health care resource utilization in schizophrenia: A national and state-level analysis of US Medicaid BeneficiariesJoseph Parks, Pin Xiang, Ravi Patel, et al.Journal of Managed Care & Specialty Pharmacy|May 21, 2026
Health care costs associated with disease progression of untreated chronic hepatitis C in the United StatesSuk-Chan Jang, Ji Haeng Heo, Shao-Hsuan Chang, et al.Journal of Managed Care & Specialty Pharmacy|June 9, 2026
Equivalent effectiveness of a prescription binocular treatment for amblyopia in real-world practiceEric D Gaier, Brenda L Bohnsack, Maria I Bodack, et al.Journal of Managed Care & Specialty Pharmacy|September 17, 2021
Using latent class and quantum models to value equity in health care: a tale of 2 storiesSurachat NgorsurachesJournal of Managed Care & Specialty Pharmacy|February 1, 2018
Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular DegenerationCharles C Wykoff, W Lloyd Clark, Jared S Nielsen, et al.Journal of Managed Care & Specialty Pharmacy|October 1, 2021
AMCP Partnership Forum: Racial health disparities-a closer look at benefit designJournal of Managed Care & Specialty Pharmacy|July 9, 2026
Prevalence of renal and bone risk factors and nucleos(t)ide analogue treatment among patients with chronic hepatitis B in the United StatesAlice E Stead, Mary J Christoph, Amanda W Singer, et al.Journal of Managed Care & Specialty Pharmacy|June 24, 2026
US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriatenessYichen Lin, Lu Shi, Molly Beinfeld, et al.Journal of Managed Care & Specialty Pharmacy|June 24, 2026
Timing of health technology assessment in the United States: An evaluation of ICER reviews over 8 yearsAbigail C Wright, Avery McKenna, Belén Herce-Hagiwara, et al.Pageof 185